D A M Heideman
Overview
Explore the profile of D A M Heideman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
1227
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dick S, Heideman D, Berkhof J, Steenbergen R, Bleeker M
Tumour Virus Res
. 2024 Dec;
19():200308.
PMID: 39694193
DNA methylation of host-cell genes is an epigenetic process that regulates gene expression and is associated with cervical cancer development. Studies on the natural history of cervical intraepithelial neoplasia (CIN)...
2.
Heideman D, Berkhof J, Verhoef L, Ouwerkerk C, Smit P, Ostrbenk Valencak A, et al.
J Clin Virol
. 2024 Feb;
171:105649.
PMID: 38335717
Background: Human papillomavirus (HPV) testing on self-samples is a valid tool for cervical cancer screening. HPV self-sample workflows need to be clinically validated to ensure safe use in screening. Objective:...
3.
Vink F, Lissenberg-Witte B, Meijer C, Berkhof J, van Kemenade F, Siebers A, et al.
Clin Microbiol Infect
. 2020 Mar;
27(1):125.e1-125.e6.
PMID: 32222459
Objectives: The aim was to evaluate the cross-sectional and long-term triage performance of FAM19A4/miR124-2 methylation analysis in human papillomavirus (HPV)-based cervical screening. Methods: We conducted a post hoc analysis within...
4.
van Veggel B, Madeira R Santos J, Hashemi S, Paats M, Monkhorst K, Heideman D, et al.
Lung Cancer
. 2020 Jan;
141:9-13.
PMID: 31926441
Objectives: Epidermal growth factor receptor (EGFR) exon 20 insertions comprise 4-10 % of EGFR mutations in non-small cell lung cancer (NSCLC) and are associated with primary resistance to first and...
5.
Heideman D, Xu L, Hesselink A, Doorn S, Ejegod D, Pedersen H, et al.
J Clin Virol
. 2019 Oct;
121:104201.
PMID: 31629967
Background: The VALidation of HPV GENoyping Tests (VALGENT) framework is designed for comparison and clinical validation of HPV assays. Objectives: To evaluate the accuracy of the HPV-Risk assay within VALGENT-4,...
6.
Rietbergen M, van Bokhoven A, Lissenberg-Witte B, Heideman D, Leemans C, Brakenhoff R, et al.
Int J Cancer
. 2018 Feb;
143(2):283-288.
PMID: 29441569
Human papillomavirus (HPV)-induced oropharyngeal squamous cell carcinoma (OPSCC) remains increasing worldwide. We aimed to investigate if the HPV-prevalence of OPSCC in the Netherlands is rising as well, also in female...
7.
Nauta I, Rietbergen M, van Bokhoven A, Bloemena E, Lissenberg-Witte B, Heideman D, et al.
Ann Oncol
. 2018 Feb;
29(5):1273-1279.
PMID: 29438466
Background: Oropharyngeal squamous cell carcinomas (OPSCCs) are traditionally caused by smoking and excessive alcohol consumption. However, in the last decades high-risk human papillomavirus (HPV) infections play an increasingly important role...
8.
Polman N, Ostrbenk A, Xu L, Snijders P, Meijer C, Poljak M, et al.
J Clin Microbiol
. 2017 Oct;
55(12):3544-3551.
PMID: 29021152
Human papillomavirus (HPV) testing is increasingly being incorporated into cervical cancer screening. The Validation of HPV Genotyping Tests (VALGENT) is a framework designed to evaluate the clinical performance of various...
9.
van der Wekken A, Kuiper J, Saber A, Terpstra M, Wei J, Hiltermann T, et al.
PLoS One
. 2017 Aug;
12(8):e0182885.
PMID: 28854272
Purpose: To determine survival in afatinib-treated patients after treatment with first-generation EGFR tyrosine kinase inhibitors (TKIs) and to study resistance mechanisms in afatinib-resistant tumors. Methods: Characteristics and survival of patients...
10.
Kuiper J, Hashemi S, Thunnissen E, Snijders P, Grunberg K, Bloemena E, et al.
Br J Cancer
. 2016 Nov;
115(12):1504-1512.
PMID: 27875527
Background: Data on non-small-cell lung cancer (NSCLC) patients with non-classic epidermal growth factor receptor (EGFR) mutations are scarce, especially in non-Asian populations. The purpose of this study was to evaluate...